101 
Market Cap
Stock Chart
Halcygen - 30 Day Poll
Recent BLOGS About Halcygen Add New
Latest Company News
|
Halcygen Pharmaceuticals Limited Announces Exercise Of Options
Reuters Key Development - Apr 19, 2010 |
|
Halcygen Pharmaceuticals Limited Announces Outcome From European Clinical Pharmacokinetic Study Comparing SUBA- Itraconazole With Sporanox
Reuters Key Development - Mar 1, 2010 |
|
Halcygen Pharmaceuticals Limited Announces Holding Interest Of Roger Aston
Reuters Key Development - Nov 11, 2009 |
|
Halcygen Pharmaceuticals Limited Announces Holding Interest of JM Financial Group Limited
Reuters Key Development - Nov 5, 2009 |
|
Halcygen Pharmaceuticals Limited Completes Acquisition Of Hospira Inc.'s Hospira Australia Pty Ltd
Reuters Key Development - Oct 30, 2009 |
|
Halcygen Pharmaceuticals Limited Announces Issue Of Fully Paid Ordinary Shares
Reuters Key Development - Oct 28, 2009 |
Website
Videos related to Halcygen
Company Profile
HalcyGen Pharmaceuticals focuses on bringing reformulated existing drugs to the market, known as SuperGenerics.
The Company has two development programmes:
1. SUBA-itraconazole and Minocycline. SUBA-itraconazole is a bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent.
2. Minocycline is a member of the tetracycline antibiotic family. Minocycline is used to treat bacterial infections, including pneumonia and other respiratory tract infections, acne and infections of skin, genital, and urinary systems. It can also be used to eliminate bacteria from the nose and throat.
Key people:
The CEO, Dr Roger Aston , has international pharma/biotech experience:
Previously at Wellcome poc (now Glaxo Smith Kline), Dr Aston has more than 20 years of experience in the pharmaceutical and biotechnology industries. His previous positions have included CEO of Peptech Limited (Australia), Director of Cambridge Antibody Technology Limited (UK) and Chairman of Cambridge Drug Discovery Limited (UK - now BioFocus pic). Dr Aston was also founder and CEO of Biokine Technology Ltd (UK) prior to its acquisition by the Peptech Group. Dr Aston was also a co-founder of pSivida Ltd.